Jacek Treliński

1.1k total citations · 1 hit paper
50 papers, 639 citations indexed

About

Jacek Treliński is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacek Treliński has authored 50 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 24 papers in Genetics and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacek Treliński's work include Platelet Disorders and Treatments (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Jacek Treliński is often cited by papers focused on Platelet Disorders and Treatments (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Jacek Treliński collaborates with scholars based in Poland, United States and Germany. Jacek Treliński's co-authors include Krzysztof Chojnowski, Tadeusz Robak, Nichola Cooper, James B. Bussel, Jerzy Windyga, Donald M. Arnold, Anne‐Marie Duliège, Francesco Zaja, Vadim Markovtsov and Jiřı́ Mayer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Toxicology and Applied Pharmacology.

In The Last Decade

Jacek Treliński

43 papers receiving 628 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

2018 237 citations James B. Bussel, Donald M. Arnold et al. American Journal of Hematology profile →

Peers

Jacek Treliński

HEMAT

GENET

PFM

IMMUN

Leonardo Campiotti Italy

Elena Pérez‐Ceballos Spain

Jennifer Herring United States

M. M. Ricetti Italy

Jason Valent United States

Nicole A. Carreau United States

Peter Bojko Germany

Milena Todorović Serbia

Yeon S. Ahn United States

Annette Feussner Germany

Leonardo Campiotti Italy

Jacek Treliński

155 ×0.4

HEMAT

174 ×0.8

GENET

95 ×0.8

67 ×0.6

PFM

38 ×0.5

IMMUN

Citations per year, relative to Jacek Treliński Jacek Treliński (= 1×) peers Leonardo Campiotti

Countries citing papers authored by Jacek Treliński

Since Specialization

Citations

This map shows the geographic impact of Jacek Treliński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Treliński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Treliński more than expected).

Fields of papers citing papers by Jacek Treliński

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Treliński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Treliński. The network helps show where Jacek Treliński may publish in the future.

Co-authorship network of co-authors of Jacek Treliński

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Treliński. A scholar is included among the top collaborators of Jacek Treliński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Treliński. Jacek Treliński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Treliński, Jacek, et al.. (2025). New treatment possibilities for refractory primary immune thrombocytopenia. Acta Haematologica Polonica. 56(5). 391–398.

Góra‐Tybor, Joanna, et al.. (2024). Professor Euzebiusz Krykowski (3 January 1927–21 March 2024). Acta Haematologica Polonica. 55(2). 60–61. 1 indexed citations

Natorska, Joanna, Javier Corral, María Eugenia de la Morena‐Barrio, et al.. (2023). Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype. Thrombosis and Haemostasis. 123(9). 880–891. 8 indexed citations

Klukowska, Anna, et al.. (2022). A series of Polish patients with congenital fibrinogen disorders: 2 new mutations in fibrinogen gamma chain, Fibrinogen Kostrzyn and Fibrinogen Łódź II. Polskie Archiwum Medycyny Wewnętrznej. 132(7-8).

Wypasek, Ewa, et al.. (2021). A case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 43-year-old female patient. Polskie Archiwum Medycyny Wewnętrznej. 131(12). 1 indexed citations

Janczar, Szymon, Anna Klukowska, Paweł Łaguna, et al.. (2020). Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland. Thrombosis Research. 193. 9–14. 8 indexed citations

Franiak‐Pietryga, Ida, Henryk Maciejewski, Barbara Ziemba, et al.. (2018). Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles. Toxicology and Applied Pharmacology. 357. 33–38. 10 indexed citations

Bogusiak, Katarzyna, et al.. (2018). Implantoprosthetic rehabilitation of a patient with severe form of hemophilia B: a case report. Acta Haematologica Polonica. 49(1). 33–36. 2 indexed citations

Bussel, James B., Donald M. Arnold, Jiřı́ Mayer, et al.. (2018). Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials. American Journal of Hematology. 93(7). 921–930. 237 indexed citations breakdown →

10.

Treliński, Jacek, et al.. (2016). Assessment of rotation thromboelastometry parameters in patients with essential thrombocythemia at diagnosis and after hydroxyurea therapy. Blood Coagulation & Fibrinolysis. 27(2). 205–209. 6 indexed citations

11.

Treliński, Jacek, et al.. (2016). Assessment of Selected ROTEM Parameters, Kinetics of Fibrinogen Polymerization and Plasmin Amidolytic Activity in Patients with Congenital Fibrinogen Defects. Advances in Clinical and Experimental Medicine. 25(6). 1255–1263. 11 indexed citations

12.

Treliński, Jacek, et al.. (2016). Assessment of oxidative/nitrative modifications of plasma proteins, selected ROTEM parameters and kinetics of fibrinogen polymerization in patients with multiple myeloma at diagnosis. Medical Oncology. 34(1). 4–4. 7 indexed citations

13.

Szymańska, J., Piotr Smolewski, Agata Majchrzak, et al.. (2015). Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines. Advances in Clinical and Experimental Medicine. 24(2). 195–202. 6 indexed citations

14.

Chojnowski, Krzysztof, et al.. (2015). Effects of Rivaroxaban Therapy on ROTEM Coagulation Parameters in Patients with Venous Thromboembolism. Advances in Clinical and Experimental Medicine. 24(6). 995–1000. 20 indexed citations

15.

Mital, Andrzej, Magdalena Łętowska, Krzysztof Chojnowski, et al.. (2013). Polskie zalecenia dotyczące leczenia antagonistami witaminy K. Via Medica Journals. 6(2). 41–47.

16.

Treliński, Jacek & Tadeusz Robak. (2013). JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms. Current Medicinal Chemistry. 20(9). 1147–1161. 21 indexed citations

17.

Treliński, Jacek, Krzysztof Chojnowski, Barbara Cebula‐Obrzut, & Piotr Smolewski. (2012). Impaired apoptosis of megakaryocytes and bone marrow mononuclear cells in essential thrombocythemia: correlation with JAK2V617F mutational status and cytoreductive therapy. Medical Oncology. 29(4). 2388–2395. 11 indexed citations

18.

Dmoszyńska, Anna, Kazimierz Kuliczkowski, Andrzej Hellmann, et al.. (2011). Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A. Haemophilia. 17(3). 456–462. 7 indexed citations

19.

Dmoszyńska, Anna, Andrzej Hellmann, Trevor Baglin, et al.. (2010). Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A. Haemophilia. 17(2). 185–190. 8 indexed citations

20.

Treliński, Jacek, et al.. (2009). The influence of low-dose aspirin and hydroxyurea on platelet–leukocyte interactions in patients with essential thrombocythemia. Blood Coagulation & Fibrinolysis. 20(8). 646–651. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact